Resources from the same session
1085 - CCTG IND 232: A Phase II Study of Durvalumab With or Without Tremelimumab in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
Presenter: Sebastien Hotte
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Abstract
1612 - Efficacy and Safety of Nivolumab in Combination With Docetaxel in Men With Metastatic Castration-Resistant Prostate Cancer in CheckMate 9KD
Presenter: Karim Fizazi
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Abstract
5387 - Health-related quality of life (HRQL) in a randomized phase 3 trial of enzalutamide with standard first line therapy for metastatic, hormone-sensitive prostate cancer (mHSPC): ENZAMET (ANZUP 1304), an ANZUP-led, international, co-operative group trial
Presenter: Martin Stockler
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Abstract
Poster Discussion – Genitourinary tumours, prostate - Invited Discussant LBA53, 850PD and 851PD
Presenter: Henrik Grönberg
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Slides
Webcast